- Home
- FINW vs FDMT Comparison
FINW vs FDMT Comparison
Compare FINW & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- FDMT
- Stock Information
- Founded
- FINW 1999
- FDMT 2013
- Country
- FINW United States
- FDMT United States
- Employees
- FINW N/A
- FDMT N/A
- Industry
- FINW Commercial Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- FINW Finance
- FDMT Health Care
- Exchange
- FINW Nasdaq
- FDMT Nasdaq
- Market Cap
- FINW 196.2M
- FDMT 207.1M
- IPO Year
- FINW 2021
- FDMT 2020
- Fundamental
- Price
- FINW $14.06
- FDMT $4.13
- Analyst Decision
- FINW Buy
- FDMT Buy
- Analyst Count
- FINW 4
- FDMT 10
- Target Price
- FINW $20.75
- FDMT $32.33
- AVG Volume (30 Days)
- FINW 18.4K
- FDMT 449.2K
- Earning Date
- FINW 07-24-2025
- FDMT 08-07-2025
- Dividend Yield
- FINW N/A
- FDMT N/A
- EPS Growth
- FINW N/A
- FDMT N/A
- EPS
- FINW 0.91
- FDMT N/A
- Revenue
- FINW $72,056,000.00
- FDMT $23,000.00
- Revenue This Year
- FINW $38.17
- FDMT $13,048.65
- Revenue Next Year
- FINW $18.44
- FDMT N/A
- P/E Ratio
- FINW $15.54
- FDMT N/A
- Revenue Growth
- FINW 7.66
- FDMT N/A
- 52 Week Low
- FINW $10.10
- FDMT $2.24
- 52 Week High
- FINW $20.94
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- FINW 42.63
- FDMT 54.45
- Support Level
- FINW $13.66
- FDMT $4.21
- Resistance Level
- FINW $14.95
- FDMT $4.62
- Average True Range (ATR)
- FINW 0.53
- FDMT 0.30
- MACD
- FINW -0.03
- FDMT -0.02
- Stochastic Oscillator
- FINW 31.25
- FDMT 37.42
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.